Summary
- Current Price
- As of today, BCRX price is $9.94, up +1.33% on
- Current Price All-Time High
- BCRX price is currently -73.32% below its historical high of $37.25 set on
- Market Cap
- BCRX current market cap is $3B, up +43.20% over the past 365 days
- Revenue
- BCRX current annual revenue is $874.84M, up +94.10% year-over-year
- Next Earnings
- The next earnings release for BCRX is on
Profile
| Metric | Value |
|---|---|
| Full Name | BioCryst Pharmaceuticals, Inc. |
| Ticker | NASDAQ: BCRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | biocryst.com |
| Employees | 580 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $9.94 | |
| Price, 1D Change | +1.33% | |
| $3B | ||
| - | ||
| - | ||
| 0.58 | ||
| $874.84M | ||
| Revenue, 1Y Change | +94.10% | |
| $1.21 | ||
| EPS, 1Y Change | +380.74% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| $1.21 | ||
| EPS Estimate | $0.75 | N/A |
| EPS Est. Change | -38.29% | N/A |
| $874.84M | ||
| Revenue Estimate | $702.23M | N/A |
| Revenue Est. Change | -19.73% | N/A |
| Current Price | $9.94 | |
| Price Target | $17.00 | - |
| Price Tgt. Change | +71.03% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.36 | -$0.43 | -20.58% | |
| $0.49 | $1.21 | +146.37% | |
| $0.75 | N/A | -38.29% | |
| $0.94 | N/A | -22.13% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $449.28M | $450.71M | +0.32% | |
| $620.20M | $874.84M | +41.06% | |
| $702.23M | N/A | -19.73% | |
| $737.28M | N/A | -15.72% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $9.94 | |
| $8.38 | ||
| $9.49 | ||
| $8.77 | ||
| $9.48 | ||
| $0.12 | ||
| 0.58 | ||
| $0.50 | ||
| 54.72 | ||
| 55.93% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $874.84M | ||
| $1.21 | ||
| $855.76M | ||
| 97.66% | ||
| $340.99M | ||
| 38.98% | ||
| $263.86M | ||
| 30.16% | ||
| $342.38M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| -3.91 | ||
| 2.06 | ||
| 2.03 | ||
| - | ||
| 4 | ||
| 2.68 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 2.70 | ||
| -5.59 | ||
| 7.81 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$119.15M | ||
| $274.95M | ||
| $514.16M | ||
| $404.35M | ||
| $633.31M | ||
| $196.07M | ||
| $465.69M | ||
| $40.08M | ||
| $15.83M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $610.98M | ||
| $514.77M | ||
| $20.46M | ||
| $348.65M | ||
| $1.39M | ||
| $0.00 | ||
| $3.53M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $329.88M | ||
| -$13.69M | ||
| -$332.44M | ||
| $2.47M | ||
| $327.41M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wedbush | → | |
| RBC Capital | → | |
| RBC Capital | → | |
| HC Wainwright & Co. | → | |
| Cantor Fitzgerald | → | |
| Wedbush | → | |
| Citizens | → | |
| Needham | → | |
| RBC Capital | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
No data
Screeners with BCRX
FAQ
- What is the ticker symbol for BioCryst Pharmaceuticals, Inc.?
- The ticker symbol for BioCryst Pharmaceuticals, Inc. is NASDAQ:BCRX
- Does BioCryst Pharmaceuticals, Inc. pay dividends?
- No, BioCryst Pharmaceuticals, Inc. does not pay dividends
- What sector is BioCryst Pharmaceuticals, Inc. in?
- BioCryst Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is BioCryst Pharmaceuticals, Inc. in?
- BioCryst Pharmaceuticals, Inc. is in the Specialty & Generic Drug Manufacturers industry
- What country is BioCryst Pharmaceuticals, Inc. based in?
- BioCryst Pharmaceuticals, Inc. is headquartered in United States
- When did BioCryst Pharmaceuticals, Inc. go public?
- BioCryst Pharmaceuticals, Inc. initial public offering (IPO) was on March 4, 1994
- Is BioCryst Pharmaceuticals, Inc. in the S&P 500?
- No, BioCryst Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is BioCryst Pharmaceuticals, Inc. in the NASDAQ 100?
- No, BioCryst Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is BioCryst Pharmaceuticals, Inc. in the Dow Jones?
- No, BioCryst Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was BioCryst Pharmaceuticals, Inc. last earnings report?
- BioCryst Pharmaceuticals, Inc.'s most recent earnings report was on August 5, 2026
- When does BioCryst Pharmaceuticals, Inc. report earnings?
- The next expected earnings date for BioCryst Pharmaceuticals, Inc. is November 2, 2026
Data Sources & References
- BCRX Official Website www.biocryst.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/882796/000162828026012240/0001628280-26-012240-index.htm
- BCRX Profile on Yahoo Finance finance.yahoo.com/quote/BCRX
- BCRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bcrx